Entity Details

Primary name MYOZ2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9NPC6
EntryNameMYOZ2_HUMAN
FullNameMyozenin-2
TaxID9606
Evidenceevidence at protein level
Length264
SequenceStatuscomplete
DateCreated2005-11-22
DateModified2021-06-02

Ontological Relatives

GenesMYOZ2

GO terms

Show/Hide Table
GOName
GO:0000122 negative regulation of transcription by RNA polymerase II
GO:0003779 actin binding
GO:0007519 skeletal muscle tissue development
GO:0015629 actin cytoskeleton
GO:0030017 sarcomere
GO:0030018 Z disc
GO:0030346 protein phosphatase 2B binding
GO:0031433 telethonin binding
GO:0043503 skeletal muscle fiber adaptation
GO:0045214 sarcomere organization
GO:0051373 FATZ binding
GO:0070885 negative regulation of calcineurin-NFAT signaling cascade

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm

Domains

Show/Hide Table
DomainNameCategoryType
IPR008438 MyozeninFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613838 OMIMCardiomyopathy, familial hypertrophic 16 (CMH16)A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. The disease is caused by variants affecting the gene represented in this entry.